Syros Pharmaceuticals

SYRS

OTCHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-110.7M

EBITDA$-33.2M

EBIT$-34.51M

Pre-tax Income$-97.82M

Net Income$-39.83M

Cash Equivalent$71.88M

Total Debt$60.7M

Book Value$-3.39M

Book Value Per Share-0.13

Return on Equity (ROE)-987.72%

Return on Assets (ROA)-97.86%

Return on Invested Capital (ROI)-284.31%

Net Profit Margin-1656.34%

Current Ratio3.95

Quick Ratio3.80

Long-Term Debt / Equity2.07